REP.DEREP.DEXETRA
Loading
EBITDA Over TimeStable
Percentile Rank43
3Y CAGR-19.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-19.8%/yr
vs +13.4%/yr prior
Acceleration
-33.1pp
Decelerating
Percentile
P43
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
2025$5.13B-8.4%
2024$5.61B-22.3%
2023$7.22B-27.4%
2022$9.93B+47.4%
2021$6.74B+1309.9%
2020$-557.00M-191.6%
2019$-191.00M-103.2%
2018$6.01B-1.3%
2017$6.09B+24.3%
2016$4.90B-